PlexusDx vs Henry Meds: GLP-1 Pricing and Plan Terms Compared (2026)

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

PlexusDx costs substantially less for injectable semaglutide across every comparable plan structure—$189 month-to-month versus $297 at Henry Meds, $894 for six months versus $1,482—but Henry Meds wins on oral semaglutide sublingual tablets at $249 month-to-month (PlexusDx $289) and offers a broader menu including liraglutide and oral tirzepatide, neither of which PlexusDx carries. Henry's advertised rates require large upfront payments for 6- or 12-month commitments; PlexusDx's multi-month pricing is billed monthly. Both providers bundle medication, shipping, and clinician visits into one flat price with no membership fee. Henry Meds carries a 4.4-star Trustpilot rating across approximately 13,000 reviews (captured September 8, 2026); PlexusDx holds a 4.3-star rating with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Choose the provider whose price, plan flexibility, and medication format best match your budget and clinical needs.

At-a-glance comparison

Injectable semaglutide: month-to-month and prepaid plans

PlexusDx charges $189 per month for injectable compounded semaglutide on a month-to-month basis, with no upfront commitment (verified September 8, 2026). A three-month plan drops the rate to $169/month billed monthly ($507 total), and a six-month plan brings it to $149/month billed monthly ($894 total). Henry Meds charges $297 per month month-to-month for the same compound (verified September 4 and 8, 2026).

Henry Meds offers two prepaid options that lower the effective monthly cost but require paying the full balance upfront: a six-month plan at $1,482 paid in full ($247/month effective, our calculation based on verified pricing captured September 4, 2026) and a 12-month plan at $2,364 paid in full ($197/month effective, our calculation based on verified pricing captured September 4, 2026). Henry Meds does not offer monthly billing on prepaid plans.

Twelve-month cost comparison, injectable semaglutide

All figures are our calculations based on verified pricing captured September 4–8, 2026. Henry Meds' 12-month prepaid plan delivers the lowest absolute cost over a year—$2,364—but requires paying the full amount upfront and commits you for 12 months. PlexusDx's six-month plan renewed twice costs $1,788 billed monthly over the year, which is $576 more than Henry's annual prepay but carries no upfront lump sum and allows monthly cancellation on the month-to-month tier. On month-to-month terms with no commitment, PlexusDx costs $1,296 less per year than Henry Meds.

Oral semaglutide: sublingual tablets and capsules

Henry Meds wins the month-to-month rate for oral semaglutide sublingual tablets at $249 per month, versus PlexusDx oral semaglutide capsules at $289/month (verified September 4 and 8, 2026). Over 12 months on a monthly plan, that difference totals $480 in Henry's favor—$2,988 versus $3,468, our calculation.

Henry Meds also offers premium semaglutide tablets or drops at $179 month-to-month, a six-month prepaid plan for oral sublingual at $1,014 upfront ($169/month effective, our calculation based on verified pricing captured September 4, 2026), and a 12-month prepaid plan at $1,788 upfront ($149/month effective, our calculation based on verified pricing captured September 4, 2026). PlexusDx does not publish multi-month discounts for oral semaglutide as of this writing. If you prefer an oral formulation and want the flexibility of monthly billing with no prepayment, Henry Meds' $249 sublingual rate is $40/month cheaper than PlexusDx's oral capsule.

Injectable tirzepatide and other GLP-1 options

PlexusDx offers injectable compounded tirzepatide at $289 month-to-month or $249/month on a six-month plan billed monthly (verified September 8, 2026). Henry Meds does not offer injectable tirzepatide (verified September 8, 2026). Henry does list an oral tirzepatide option at $891 prepaid for three months ($297/month effective, our calculation based on verified pricing captured September 4, 2026), though the product page carries conflicting language about supply duration ("delivered every 60 days for 6 months" versus "3 months supply") captured September 4, 2026; readers should confirm the exact term and delivery schedule at checkout.

Henry Meds uniquely offers liraglutide injection at $179 month-to-month, $894 for six months prepaid ($149/month effective, our calculation based on verified pricing captured September 4, 2026), or $1,428 for 12 months prepaid ($119/month effective, our calculation based on verified pricing captured September 4, 2026). PlexusDx does not carry liraglutide. If your provider recommends liraglutide or you have tried it successfully in the past, Henry is the only option in this comparison.

Plan flexibility, cancellation, and prepayment

PlexusDx allows you to cancel anytime on the month-to-month plan (verified September 8, 2026). Multi-month plans (three-month and six-month) are billed monthly—you pay $169 or $149 each month, not a lump sum upfront—and lock in that rate for the plan duration.

Henry Meds states you can cancel anytime via your account page, email (ask@henrymeds.com), or phone (909-787-2342), but multi-month prepaid plans may require paying out the remaining balance unless a medical reason is determined by a provider (verified September 8, 2026). This means if you prepay $2,364 for 12 months of injectable semaglutide and wish to stop after six months, you may not receive a prorated refund without provider approval. The month-to-month $297 plan carries no such constraint.

If budget predictability and the lowest absolute annual cost matter most, and you are confident you will continue for a full year, Henry's $2,364 prepaid injectable semaglutide plan saves money compared to PlexusDx's six-month renewable approach. If you want to avoid a large upfront payment or preserve the option to stop without financial penalty, PlexusDx's monthly-billed structure offers more flexibility at a higher total cost than Henry's prepaid tiers but a lower cost than Henry's month-to-month rate.

What's included and how quickly medication arrives

Both providers bundle medication, clinician consultations, and shipping into the published monthly price with no separate membership fee (verified September 4 and 8, 2026). Henry Meds explicitly includes injection supplies; PlexusDx does not itemize supplies separately but they are standard with injectable orders. PlexusDx offers an optional genetic-variation report for $298 standalone or $99 for active program members, plus a complimentary check-in with a Doctor of Pharmacy; Henry Meds does not advertise genetic testing or pharmacist consultations as of the September 2026 capture.

Henry Meds reports that most patients receive medication within 8–10 business days after the provider consultation, with shipments arriving every 45 days for injectables or every 90 days for oral tablets; California orders may experience longer fulfillment times due to additional state testing requirements (verified September 8, 2026). PlexusDx does not publish a standard delivery window on its product pages as of September 8, 2026; prospective patients should confirm expected ship times during intake.

Review record and service quality

Henry Meds carries a 4.4-star Trustpilot rating based on approximately 13,000 reviews (captured September 8, 2026), one of the largest review volumes among compounded GLP-1 telehealth providers. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Both ratings fall within the range typical of established telehealth weight-management programs; individual experiences vary, and review platforms capture a non-random sample of users who choose to post feedback.

Regulatory and compounding disclosures

Henry Meds works with licensed compounding pharmacies and outsourcing facilities regulated under federal pharmacy compounding rules (verified September 8, 2026). Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient based on medical history, current health status, and weight-management goals. Neither provider guarantees eligibility, medication availability, specific dosing, or clinical outcomes.

Choose PlexusDx if…

• You want injectable semaglutide at the lowest month-to-month rate with no upfront payment—$189 versus Henry's $297.
• You prefer to lock in a multi-month discount ($169 or $149/month) while keeping monthly billing rather than paying thousands upfront.
• You are considering injectable tirzepatide, which Henry Meds does not offer.
• You value optional genetic-variation analysis or want a complimentary pharmacist check-in as part of your program.

Choose Henry Meds if…

• You want oral semaglutide sublingual tablets at $249/month, $40 cheaper than PlexusDx's oral capsules.
• You are willing and able to prepay $2,364 upfront for injectable semaglutide to secure the lowest 12-month cost.
• Your provider recommends liraglutide, which PlexusDx does not carry.
• You prefer a provider with a larger volume of public reviews (approximately 13,000 on Trustpilot) and a slightly higher aggregate rating (4.4 stars).
• You want premium semaglutide tablets or drops at the $179 ongoing rate, Henry's most affordable semaglutide entry point.

Methodology and freshness

Pricing and plan terms were captured from public-facing product pages and verified across multiple page loads on September 4 and September 8, 2026. PlexusDx pricing reflects the published rates on the injectable semaglutide, oral semaglutide, and injectable tirzepatide product pages. Henry Meds pricing reflects advertised rates on the homepage and dedicated medication pages for injectable semaglutide, oral semaglutide (sublingual tablets and premium tablets/drops), oral tirzepatide, and liraglutide injection. Twelve-month totals and effective monthly rates for prepaid plans are our calculations based on verified per-plan prices. Review ratings and volumes were captured from Trustpilot on the dates indicated. We documented one internal inconsistency on Henry's oral tirzepatide page (conflicting supply-duration language) and recommend confirming that term at checkout. No promotional codes, first-month discounts, or limited-time offers were applied; all figures represent standard or prepaid ongoing rates as published. This comparison does not constitute medical advice, and eligibility for any medication is determined solely by a licensed clinician reviewing your individual health history.

Frequently Asked Questions

Does Henry Meds require paying the full year upfront for the lowest injectable semaglutide rate?

Yes. Henry Meds' lowest effective monthly rate for injectable semaglutide—our calculation based on verified pricing captured September 4, 2026—requires a single upfront payment of $2,364 for 12 months. Canceling mid-term may require paying the remaining balance unless a provider determines a medical reason supports early termination.

Can I get injectable tirzepatide from Henry Meds?

No. Henry Meds does not offer injectable tirzepatide as of September 8, 2026. The company does list an oral tirzepatide option, but the product page contains conflicting language about supply duration; confirm the exact term before ordering. PlexusDx offers injectable tirzepatide at $289/month or $249/month on a six-month plan.

Which provider is cheaper for oral semaglutide?

Henry Meds' oral sublingual semaglutide costs $249/month on a month-to-month plan, $40 less than PlexusDx's $289/month oral capsules (verified September 4 and 8, 2026). Over 12 months that difference totals $480, our calculation. Henry also offers a premium tablet or drop formulation at $179/month and prepaid plans with effective monthly rates our calculation shows to be as low as $149/month for 12 months paid upfront.

Does PlexusDx require a large upfront payment for multi-month plans?

No. PlexusDx's three-month and six-month plans are billed monthly at the discounted rate—$169 or $149 per month for injectable semaglutide—rather than requiring the full balance upfront (verified September 8, 2026). You lock in the lower rate for the plan term but pay each month, not as a lump sum.

What is liraglutide and which provider offers it?

Liraglutide is a GLP-1 receptor agonist (brand name Victoza or Saxenda) with FDA approval for weight management, though compounded versions are not FDA-approved. Henry Meds offers compounded liraglutide injection starting at $179/month; prepaid plans yield effective monthly rates our calculation shows to be as low as $119/month for 12 months paid upfront (verified September 4, 2026). PlexusDx does not carry liraglutide.

Sources

• PlexusDx injectable semaglutide product page, accessed September 8, 2026
• PlexusDx oral semaglutide product page, accessed September 8, 2026
• PlexusDx injectable tirzepatide product page, accessed September 8, 2026
• Henry Meds homepage and GLP-1 medication landing pages, accessed September 8, 2026
• Henry Meds injectable semaglutide, oral semaglutide, oral tirzepatide, and liraglutide product pages, verified September 4, 2026
• Henry Meds cancellation and delivery policy pages, accessed September 8, 2026
• Trustpilot profiles for PlexusDx and Henry Meds, captured September 4 and September 8, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.